HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
The inspection concluded with the issuance of a form 483 with five observations
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Developed in consultation with clinicians and patients for an enhanced user experience
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Subscribe To Our Newsletter & Stay Updated
